Lv22
190 积分 2023-05-13 加入
Aurora A Inhibition Eliminates Myeloid Cell–Mediated Immunosuppression and Enhances the Efficacy of Anti–PD-L1 Therapy in Breast Cancer
3分钟前
已完结
Urothelial carcinoma: the development of FGFR inhibitors in combination with immune checkpoint inhibitors
18分钟前
已完结
Efficacy and safety of ongericimab in Chinese statin-intolerant patients with primary hypercholesterolemia or mixed dyslipidemia: a randomized, placebo-controlled phase 3 trial
5小时前
已完结
Aprepitant Versus Dexamethasone for Preventing Chemotherapy-Induced Delayed Emesis in Patients With Breast Cancer: A Randomized Double-Blind Study
3天前
已完结
Safety of HTX-019 (intravenous aprepitant) and fosaprepitant in healthy subjects
3天前
已完结
Safety of HTX-019 (intravenous aprepitant) and fosaprepitant in healthy subjects
3天前
已关闭
Safety of HTX-019 (intravenous aprepitant) and fosaprepitant in healthy subjects
3天前
已关闭
Safety of HTX-019 (intravenous aprepitant) and fosaprepitant in healthy subjects
3天前
已关闭
Safety and tolerability of intravenous aprepitant and fosaprepitant in children with cancer: A retrospective, single‐center review
3天前
已完结
A phase 1 dual‐dose escalation study of radiation and nab‐paclitaxel in patients with unresectable and borderline resectable pancreatic cancer
18天前
已完结
皖公网安备34019202002308
